Moreover, regardless of tumor differentiation grade, tumor size, TNM stage, and aspartate transaminase (AST) and AFP levels, peritumoral CXCL17 was a good predictor of recurrence (all P<0.05, Fig. S5). This evidence concerns the gene CXCL17 and neoplasm.